Exit Cervical Cancer Screening Guidelines—Pre-test Question Title * 1. How do new recommendations on cervical cancer screening from the American Cancer Society differ from previous consensus guidelines? Select all that apply. The age of initiation is raised from 21 to 25 Primary HPV testing is the preferred screening strategy A 3-year screening interval is recommended for Pap and HPV co-testing Screening is no longer recommended for vaccinated patients Question Title * 2. Which of the following is not one of the considerations behind the ACS screening guidelines? HPV primary screening before age 25 results in many positive test that may be transient. Cytology remains the most important test for determining cancer risk. Sensitivity of screening method requires different screening intervals. Question Title * 3. Which screening strategies are more likely to detect cervical intraepithelial neoplasia? Select all that apply. Cytology hrHPV testing Co-testing (cytology and hrHPV testing) Question Title * 4. What screening modality is preferred by professional societies including ACOG, ASCCP and SGO? Cytology alone every three years hrHPV testing alone every five years Co-testing (cytology and hrHPV testing) every five years There is no preferred option Question Title * 5. What barriers exist to more widespread HPV primary testing? Select all that apply. Laboratory infrastructure High HPV vaccination rates Access to care Patient resistance to five year intervals Question Title * 6. By listening to this podcast, I hope to be better able to: Thank you for completing this pre-test. If you have any questions, please contact info@ashasexualhealth.org. Question Title Done